Waterford, CT, United States of America

John B Cheng


Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 59(Granted Patents)


Company Filing History:


Years Active: 1994-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of John B Cheng

Introduction

John B Cheng is a notable inventor based in Waterford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds. With a total of 4 patents, Cheng's work has the potential to impact various medical conditions.

Latest Patents

Cheng's latest patents include groundbreaking methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2. This invention highlights the discovery that PDG is the natural ligand for orphan receptor CRTH2, which is crucial for developing valuable pharmaceuticals. The methods outlined in this patent focus on screening therapeutic compounds for PGD-related disorders such as allergy, asthma, and inflammation. Another significant patent involves nicotinamide derivatives, which are compounds useful in treating a wide range of disorders, including respiratory, allergic, and inflammatory diseases, as well as central nervous system disorders.

Career Highlights

Throughout his career, John B Cheng has worked with prominent organizations, including Pfizer Corporation. His experience in the pharmaceutical industry has allowed him to contribute to innovative solutions for complex health issues.

Collaborations

Cheng has collaborated with notable professionals in his field, including Anthony Marfat and Robert James Chambers. These partnerships have further enhanced his research and development efforts.

Conclusion

John B Cheng's innovative work and patents reflect his dedication to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…